Myriad Genetics, Inc.MYGNNASDAQ
Loading
SG&A Expenses Over TimeStable
Percentile Rank71
3Y CAGR+1.5%
5Y CAGR+1.4%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+1.5%/yr
vs -1.9%/yr prior
5Y CAGR
+1.4%/yr
Consistent
Acceleration
+3.4pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStable
PeriodValueYoY Change
TTM$537.60M-4.0%
2024$560.00M-2.3%
2023$572.90M+11.3%
2022$514.70M-4.3%
2021$537.80M+7.4%
2020$500.70M-1.3%
2019$507.30M-8.9%
2018$556.60M+19.2%
2017$467.10M-2.0%
2016$476.40M-